// company-profile

Kymera Therapeutics, Inc.

KYMR
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings125Insiders38
// api This Kymera Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 4 insiders purchased shares versus 2 sales. Buying was led by Booth Bruce.

// 90-day insight

Over the last 90 days, Kymera Therapeutics, Inc. insiders bought $292K (7 transactions) and sold $318K (2 transactions).

  • Most active insider: Booth Bruce with 35 transactions totaling $48.8M.
  • Largest single sale: $8.3M by Booth Bruce on Jun 17, 2026.
  • 95% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Kymera Therapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$6.77B
QoQ change
+11.3%
Reporting period
2026-03-31
#1
BAKER BROS. ADVISORS LP
CIK 1263508
$721.1M
8.7M shares
#2
FMR LLC
CIK 315066
$665.4M
8.0M shares
#3
Avoro Capital Advisors LLC
CIK 1633313
$622.6M
7.5M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 22, 2026Booth BruceKYMR
Sale10b5
56,348$100.17$5.64M
Jun 22, 2026Booth BruceKYMR
Sale10b5
2,035$94.48$192K
Jun 22, 2026Booth BruceKYMR
Sale10b5
6,597$101.61$670K
Jun 22, 2026Booth BruceKYMR
Sale10b5
52,442$99.57$5.22M
Jun 22, 2026Booth BruceKYMR
Sale10b5
20,903$96.24$2.01M

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.